Back
Omeros 10K Form
Buy
67
OMER
Omeros
Last Price:
4.26
Seasonality Move:
14.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-15 | 10Q | OMER/Omeros Quarterly |
| 2024-04-01 | 10K | OMER/Omeros Annual |
| 2023-11-09 | 10Q | OMER/Omeros Quarterly |
| 2023-08-09 | 10Q | OMER/Omeros Quarterly |
| 2023-05-09 | 10Q | OMER/Omeros Quarterly |
| 2023-05-01 | 10K | OMER/Omeros Annual |
Receive OMER News And Ratings
See the #1 stock for the next 7 days that we like better than OMER
OMER Financial Statistics
Sales & Book Value
| Annual Sales: | $73.81M |
|---|---|
| Cash Flow: | $-46.07M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.15 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.35000 |
|---|---|
| Net Income (TTM): | $-140.04M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Omeros Earnings Forecast
Key Omeros Financial Ratios
- The Selling, General & Administrative Expenses for OMER have been equal to 66.80% of Gross Profit Margin.
- The Interest Expense is -26.18% of Operating Income.
- Per Share Earnings over the last 18 years have been positive in 9 years.
Omeros Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | OMER |
| CUSIP: | 682143 |
| Website: | omeros.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |